Stay updated on Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial

Sign up to get notified when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision history updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:33:28.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The displayed revision changed from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:47:49.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    Administrative updates: Revision: v3.4.2 was added, while Revision: v3.4.1 and a government funding/status notice were removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:25:25.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added a government funding lapse notice at the top with a link to opm.gov, and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T07:54:28.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    UI/metadata updates include showing the glossary, adding 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', and removing or altering older labels ('Last Update Submitted that met QC Criteria' and 'Revision: v3.3.4') as well as changes to 'No FEAR Act Data'.
    Difference
    0.2%
    Check dated 2026-01-28T04:44:39.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No substantive study information or documents were changed.
    Difference
    0.1%
    Check dated 2026-01-14T02:38:56.000Z thumbnail image

Stay in the know with updates to Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.